Skip to main content
logo
Avadel Pharmaceuticals plc (AVDL)
21.64
+0.01 (0.05%)
Inactive · Last trade price on Feb 11, 2026

Avadel Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
248.52169.1227.96--22.33
Revenue Growth
79.88%504.79%----62.28%
Gross Profit
235.88153.8427.12--16.59
Operating Income
4.52-42.4-137.85-98.56-85.555.82
Net Income
-0.28-48.83-160.28-137.46-77.337.03
Earnings Per Share
-0.00-0.51-2.00-2.29-1.320.13
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
91.5873.78105.1196.5157.22221.4
Total Debt
2.551.72.62131.02145130.52
Net Cash (Debt)
89.0372.07102.49-34.5212.2290.88
Net Cash Growth
39.40%-29.68%---86.56%-
Net Cash Per Share
0.910.761.28-0.570.211.65

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
34.54-46.91-128.51-70.3-77.31-48.73
Capital Expenditures
----0.72-0.03-0.1
Free Cash Flow
34.54-46.91-128.51-71.02-77.34-48.83
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
94.91%90.97%96.97%--74.29%
Operating Margin
1.82%-25.07%-492.97%--26.04%
Pretax Margin
-1.31%-29.02%-574.96%---22.75%
Profit Margin
-0.11%-28.87%-573.17%--31.47%
FCF Margin
13.90%-27.74%-459.58%---218.64%

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PE Ratio
-----51.38
Forward PE
33.17200.19----
PS Ratio
8.426.0045.36--17.47